Company filings profile · CIK 0001191070
Neuphoria Therapeutics Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Neuphoria Therapeutics Inc. (NEUP): 7 filings in the last 90 days vs 2 in the prior 90 (filing-velocity rising ↑ · 3.5×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 19, 2026. Source-linked, daily-refreshed.
Material 8-K events — Neuphoria Therapeutics Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Jul 24, 2026 | Entry into a Material Agreement; Change in Control; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 26, 2026 | Other Events | ↗ |
| Jan 8, 2026 | Entry into a Material Agreement; Termination of a Material Agreement; Financial Statements and Exhibits | ↗ |
| Dec 18, 2025 | Delisting / Listing-Rule Failure | ↗ |
| Dec 17, 2025 | Item 5.07 | ↗ |
Watch Neuphoria Therapeutics Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 18, 2026 | DEFA14A | DEFA14A | ↗ |
| Sep 18, 2026 | DEFA14A | DEFA14A | ↗ |
| Sep 18, 2026 | DEF 14A | DEF 14A | ↗ |
| Sep 18, 2026 | 10-K | 10-K | ↗ |
| Jul 28, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 24, 2026 | DEFA14A | CURRENT REPORT | ↗ |
| Jul 24, 2026 | 8-K | Entry into a Material Agreement; Change in Control; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 26, 2026 | 8-K | Other Events | ↗ |
| May 15, 2026 | 10-Q | 10-Q | ↗ |
| Feb 17, 2026 | 10-Q | 10-Q | ↗ |
| Feb 6, 2026 | SCHEDULE 13G/A | ↗ | |
| Jan 21, 2026 | 4 | ↗ | |
| Jan 21, 2026 | 4 | ↗ | |
| Jan 21, 2026 | 4 | ↗ | |
| Jan 21, 2026 | 4 | ↗ | |
| Jan 8, 2026 | 8-K | Entry into a Material Agreement; Termination of a Material Agreement; Financial Statements and Exhibits | ↗ |
| Dec 29, 2025 | SCHEDULE 13D/A | ↗ | |
| Dec 18, 2025 | 8-K | Delisting / Listing-Rule Failure | ↗ |
| Dec 17, 2025 | 8-K | Item 5.07 | ↗ |
| Dec 8, 2025 | DFAN14A | DFAN14A | ↗ |
| Dec 8, 2025 | DFAN14A | DFAN14A | ↗ |
| Dec 8, 2025 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ↗ |
| Dec 4, 2025 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ↗ |
| Dec 3, 2025 | DFAN14A | DFAN14A | ↗ |
| Dec 2, 2025 | DFAN14A | DFAN14A | ↗ |
| Dec 2, 2025 | SCHEDULE 13D/A | ↗ | |
| Dec 1, 2025 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ↗ |
| Nov 28, 2025 | SCHEDULE 13D/A | ↗ | |
| Nov 26, 2025 | DFAN14A | DFAN14A | ↗ |
| Nov 25, 2025 | DFRN14A | DFRN14A | ↗ |
| Nov 25, 2025 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ↗ |
| Nov 24, 2025 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ↗ |
| Nov 24, 2025 | DEFC14A | DEFC14A | ↗ |
| Nov 24, 2025 | DEFC14A | DEFC14A | ↗ |
| Nov 18, 2025 | SCHEDULE 13D/A | ↗ | |
| Nov 14, 2025 | PREC14A | PREC14A | ↗ |
| Nov 14, 2025 | 424B5 | PROSPECTUS SUPPLEMENT | ↗ |
| Nov 14, 2025 | 10-Q | 10-Q | ↗ |
| Nov 12, 2025 | DEFA14A | SOLICITING MATERIAL UNDER 240. RULE 14A-12 | ↗ |
| Nov 12, 2025 | PREC14A | PREC14A | ↗ |